AVPpred: collection and prediction of highly effective antiviral peptides.
Open accessThe DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Abstract
In the battle against viruses, antiviral peptides (AVPs) had demonstrated the immense potential. Presently, more than 15 peptide-based drugs are in various stages of clinical trials. Emerging and re-emerging viruses further emphasize the efforts to accelerate antiviral drug discovery efforts. Despite, huge importance of the field, no dedicated AVP resource is available. In the present study, we have collected 1245 peptides which were experimentally checked for antiviral activity targeting important human viruses like influenza, HIV, HCV and SARS, etc. After removing redundant peptides, 1056 peptides were divided into 951 training and 105 validation data sets. We have exploited various peptides sequence features, i.e. motifs and alignment followed by amino acid composition and physicochemical properties during 5-fold cross validation using Support Vector Machine. Physiochemical properties-based model achieved maximum 85% accuracy and 0.70 Matthew's Correlation Coefficient (MCC). Performance of this model on the experimental validation data set showed 86% accuracy and 0.71 MCC which is far better than the general antimicrobial peptides prediction methods. Therefore, AVPpred-the first web server for predicting the highly effective AVPs would certainly be helpful to researchers working on peptide-based antiviral development. The web server is freely available at http://crdd.osdd.net/servers/avppred.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Casein hydrolysis can give rise mainly to opioid/anti-opioid peptides, antithrombotic and antihypertensive, immunomodulatory, mineral-binding and antimicrobial peptides (Thakur et al., 2012)”
From Bioactive Molecules Released in Food by Lactic Acid Bacteria: Encrypted Peptides and Biogenic Amines (2016) · cites this paper as Thakur et al., 2012
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MEME SUITE: tools for motif discovery and searching
Bailey, T. L., Boden, M., Buske, F. A., Frith, M., Grant, C. E., Clementi, L., Ren, J., Li, W. W., & Noble, W. S. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp335 · Cited by 10,648 · cited 2×
“Correct prediction of MEME/MAST depends on E-values.”
MethodAntimicrobial peptides: pore formers or metabolic inhibitors in bacteria?
Brogden, K. A. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1098 · Cited by 5,829
Fitting a mixture model by expectation maximization to discover motifs in biopolymers.
Bailey, T. L., & Elkan, C. (1994) · PubMed · Cited by 5,806
Jenssen, H., Hamill, P., & Hancock, R. E. W. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.00056-05 · Cited by 2,518
Designing antimicrobial peptides: form follows function
Fjell, C. D., Hiss, J. A., Hancock, R. E. W., & Schneider, G. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3591 · Cited by 2,035
AAindex: Amino Acid Index Database
Kawashima, S., Ogata, H., & Kanehisa, M. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.1.368 · Cited by 1,012
APD2: the updated antimicrobial peptide database and its application in peptide design.
Wang, G., Li, X., & Wang, Z. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn823 · Cited by 941
AAindex: Amino Acid index database
Kawashima, S. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.374 · Cited by 791
AlgPred: prediction of allergenic proteins and mapping of IgE epitopes
Saha, S., & Raghava, G. P. S. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl343 · Cited by 753
CAMP: a useful resource for research on antimicrobial peptides.
Thomas, S., Karnik, S., Barai, R. S., Jayaraman, V. K., & Idicula-Thomas, S. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkp1021 · Cited by 462 · cited 8×
“About 150 AVP of our collection were also present in the existing antimicrobial databases (21,22).”
BackgroundInfluentialAntimicrobial Peptides: Primeval Molecules or Future Drugs?
Peters, B. M., Shirtliff, M. E., & Jabra-Rizk, M. A. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001067 · Cited by 425
Lambert, D. M., Barney, S., Lambert, A. L., Guthrie, K., Medinas, R., Davis, D. E., Bucy, T., Erickson, J., Merutka, G., & Petteway, S. R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.5.2186 · Cited by 336
AntiBP2: improved version of antibacterial peptide prediction
Lata, S., Mishra, N. K., & Raghava, G. P. (2010) · BMC Bioinformatics · doi:10.1186/1471-2105-11-s1-s19 · Cited by 283
Connecting Peptide Physicochemical and Antimicrobial Properties by a Rational Prediction Model
Torrent, M., Andreu, D., Nogués, V. M., & Boix, E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016968 · Cited by 260
Dwyer, J. J., Wilson, K. L., Davison, D. K., Freel, S. A., Seedorff, J. E., Wring, S. A., Tvermoes, N. A., Matthews, T. J., Greenberg, M. L., & Delmedico, M. K. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701478104 · Cited by 238
Histatins: Antimicrobial peptides with therapeutic potential
Kavanagh, K., & Dowd, S. (2004) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357022971 · Cited by 223
Prediction of Antimicrobial Peptides Based on Sequence Alignment and Feature Selection Methods
Wang, P., Hu, L., Liu, G., Jiang, N., Chen, X., Xu, J., Zheng, W., Li, L., Tan, M., Chen, Z., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018476 · Cited by 201
Rashid, M., Saha, S., & Raghava, G. P. (2007) · BMC Bioinformatics · doi:10.1186/1471-2105-8-337 · Cited by 135
High-performance signal peptide prediction based on sequence alignment techniques
Frank, K., & Sippl, M. J. (2008) · Bioinformatics · doi:10.1093/bioinformatics/btn422 · Cited by 135
Phage Display of Combinatorial Peptide Libraries: Application to Antiviral Research
Castel, G., Chtéoui, M., Heyd, B., & Tordo, N. (2011) · Molecules · doi:10.3390/molecules16053499 · Cited by 131
Antiviral Peptides Targeting the West Nile Virus Envelope Protein
Bai, F., Town, T., Pradhan, D., Cox, J., Ashish, Ledizet, M., Anderson, J. F., Flavell, R. A., Krueger, J. K., Koski, R. A., et al. (2006) · Journal of Virology · doi:10.1128/jvi.01840-06 · Cited by 117
Popović, S., Urbán, E. Z., Lukić, M. L., & Conlon, J. M. (2012) · Peptides · doi:10.1016/j.peptides.2012.02.010 · Cited by 73
Svenson, J., Karstad, R., Flaten, G. E., Brandsdal, B. O., Brandl, M., & Svendsen, J. S. M. (2009) · Molecular Pharmaceutics · doi:10.1021/mp900057k · Cited by 59
VIRsiRNAdb: a curated database of experimentally validated viral siRNA/shRNA
Thakur, N., Qureshi, A., & Kumar, M. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr1147 · Cited by 55
Self-citationWunderlich, K., Juozapaitis, M., Ranadheera, C., Kessler, U., Arnold, M., Eisel, J., Beutling, U., Frank, R., & Schwemmle, M. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01419-10 · Cited by 54
Antiviral Drug Discovery Strategy Using Combinatorial Libraries of Structurally Constrained Peptides
Réal, É., Rain, J., Battaglia, V., Jallet, C., Perrin, P., Tordo, N., Chrisment, P., d’Alayer, J., Legrain, P., & Jacob, Y. (2004) · Journal of Virology · doi:10.1128/jvi.78.14.7410-7417.2004 · Cited by 49
Multiple Peptides Homologous to Herpes Simplex Virus Type 1 Glycoprotein B Inhibit Viral Infection
Akkarawongsa, R., Pocaro, N. E., Case, G. L., Kolb, A. W., & Brandt, C. R. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00793-08 · Cited by 48
Identification of the Minimal Active Sequence of an Anti-Influenza Virus Peptide
Jones, J. C., Settles, E. W., Brandt, C. R., & Schultz‐Cherry, S. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01428-10 · Cited by 26
Design and optimization of a multiplex anti-influenza peptide immunoassay
Drummond, J. E., Shaw, E., Antonello, J. M., Green, T., Page, G. J., Motley, C. O., Wilson, K. A., Finnefrock, A. C., Liang, X., & Casimiro, D. R. (2008) · Journal of Immunological Methods · doi:10.1016/j.jim.2008.01.017 · Cited by 22
Narumi, T., Komoriya, M., Hashimoto, C., Wu, H., Nomura, W., Suzuki, S., Tanaka, T., Chiba, J., Yamamoto, N., Murakami, T., et al. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.12.055 · Cited by 19
Vaccination: the present and the future.
Sadanand, S. (2011) · PubMed Central · Cited by 17
Inhibition of Influenza Virus Replication by Constrained Peptides Targeting Nucleoprotein
Jiang, H., Xu, Y., Li, L., Weng, L., Wang, Q., Zhang, S., Jia, B., Hu, H., He, Y., Jacob, Y., et al. (2011) · Antiviral chemistry & chemotherapy · doi:10.3851/imp1902 · Cited by 13
5. Vaccination: The Present and Future
Botting, J. H. (2015) · Open Book Publishers · doi:10.11647/obp.0055.05 · Cited by 11
Peptide Inhibitors of Hepatitis C Virus NS3 Protease
Portal‐Núñez, S., González-Navarro, C. J., García‐Delgado, M., Vizmanos, J. L., Lasarte, J. J., & Borrás‐Cuesta, F. (2003) · Antiviral chemistry & chemotherapy · doi:10.1177/095632020301400501 · Cited by 10
Cited by
Meher, P. K., Sahu, T. K., Saini, V., & Rao, A. R. (2017) · Scientific Reports · doi:10.1038/srep42362 · Cited by 516
Antimicrobial Peptides: Features, Action, and Their Resistance Mechanisms in Bacteria
Moravej, H., Moravej, Z., Yazdanparast, M., Heiat, M., Mirhosseini, A., Moosazadeh Moghaddam, M., & Mirnejad, R. (2018) · Microbial Drug Resistance · doi:10.1089/mdr.2017.0392 · Cited by 410
Antimicrobial Peptides: An Update on Classifications and Databases
Bin Hafeez, A., Jiang, X., Bergen, P. J., & Zhu, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111691 · Cited by 341
Bhadra, P., Yan, J., Li, J., Fong, S., & Siu, S. W. I. (2018) · Scientific Reports · doi:10.1038/s41598-018-19752-w · Cited by 339
Bioactive Molecules Released in Food by Lactic Acid Bacteria: Encrypted Peptides and Biogenic Amines
Pessione, E., & Cirrincione, S. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00876 · Cited by 333
“7:876. doi: 10.3389/fmicb.2016.00876 Bioactive Molecules Released in Food by Lactic Acid Bacteria: Encrypted Peptides and Biogenic Amines Enrica Pessione* and Simona Cirrincione Laboratory of Biochemistry, Proteomics and Metabolic Engineering of Prokaryotes, Department of Life Sciences and Systems Biology, University…”
BackgroundInfluential
Metadata
- Authors
- Thakur, N., Qureshi, A., & Kumar, M.
- Affiliations
- Institute of Microbial Technology (IN)
- Corresponding author
- Kumar, Manoj
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-05-24
- Volume
- 40
- Issue
- W1
- Pages
- W199-W204
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- PMC
- PMC3394244
- OpenAlex
- W2097834518
- Cited by
- 324
- References
- 34
- Citations by year
- 2026: 18 · 2025: 39 · 2024: 43 · 2023: 33 · 2022: 41 · 2021: 44 · 2020: 36 · 2019: 13 · 2018: 17 · 2017: 7 · 2016: 9 · 2015: 6 · 2014: 8 · 2013: 8 · 2012: 1
- FWCI
- 6.36
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nucleic Acids Research (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- HighWire Press Open Archive (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Antimicrobial Peptides and Activities
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Machine Learning in Bioinformatics
- Keywords
- antiviral peptides, antiviral activity prediction, physicochemical properties, amino acid composition, support vector machine, influenza, HIV, hepatitis C virus, SARS coronavirus
- MeSH terms
- Algorithms, Amino Acids, Antiviral Agents, Peptides, Software, Sequence Alignment, Internet, Sequence Analysis, Protein, Amino Acid Motifs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

